New job opportunity

This is an opportunity for candidates with a higher science degree and experience or strong interest in the diagnostic, pharmaceutical or medical device industry. High level of skills in physics, statistics and measurement techniques are required.
If you are attracted by a small, innovative organization in an international arena, then Gentian can be an interesting workplace for you.

Gentian supports Oslo Medtech and Oslo Innovation Magazine

Gentian is expanding and moves to new facility in Moss, Norway

Gentian moves into a new facility on 27th September. Increased sales; increased production; and exciting international development projects need more space. Larger offices and laboratories, conference room, more parking and easy access from the E18 come with the updated facility. New and original diagnostics are in the pipeline and more employment opportunities are being created as our expanded production capacity moves into high gear.
Click here to get directions to our new location.

Gentian signs distribution agreement with Eurobio Laboratoires in France

Eurobio Laboratoires (Courtaboeuf, France) and Gentian announce an agreement to bring the Gentian Cystatin C Immunoassay to the medical community for use in the diagnosis and treatment of renal diseases and early detection of cardiovascular disease in France, North Africa and the French Island Territories.

Mayo Clinic adopts the Gentian Cystatin C turbidimetric method for cystatin C testing

Oslo, 25th August 2011.

Gentian’s announces that The Mayo Clinic’s Renal Function Laboratory has implemented the Gentian Cystatin C immunoassay method for renal function assessment and measurement of GFR.

Mayo Clinic’s Renal Function Laboratory studies indicate that cystatin C can be accurately measured by particle-enhanced turbidimetric assay (PETIA) on a routine chemistry analyzer, and then used to estimate glomerular filtration rate (GFR). Advantages of this assay over the previously offered particle-enhanced nephelometric immunoassay (PENIA) include improved turnaround time and standardization to international reference material.

Read more about why the Mayo Clinic has adopted the Gentian method in the communique on the Mayo Clinic frontpage.
Read the communique here: Mayo Clinic Cystatin C Communique Article
Listen to the communique in an audio file here: Mayo Clinic Cystatin C Communique Play.

Gentian Cystatin C Assay Added to UCLA’s Outreach Testing Program

PRESS RELEASE:
Oslo, 25th October 2010.

Gentian’s distributor, Atlantic Diagnostics, LLC announces that the UCLA (University of California, Los Angeles) Department of Pathology & Lab Medicine, CIRL, has added the Gentian Cystatin C immunoassay to its Outreach testing program.

The UCLA Department of Pathology & Lab Medicine, CIRL Outreach program is a specialized testing service for those clinical institutions that wish to have specimens tested and confirmed through their laboratory facility.

Gentian calibrates against the new world standard Cystatin C reference material starting from 15th August 2010

Gentian is the first Cystatin C immunoassay manufacturer to calibrate their Cystatin C products against the newly introduced world standard Cystatin C reference material ERM - DA471/IFCC. Calibration was implemented from 15th August 2010.

In November 2008, Gentian Cystatin C calibrator was already evaluated against the material used in the new IFCC Cystatin C standard.
Click here to read the whole story.

Gentian cystatin C assay is best in test with turbid serum samples

A new study comparing turbidity interference of Gentian, Dako, Diazyme and Roche cystatin C immunoassays was presented on poster at the European Biomarkers Summit, Barcelona November 5-6, 2009. The study, carried out at Buskerud Hospital in Drammen, Norway and Länssjukhuset Halmstad, Sweden, shows that Roche Tina-quant, Dako and Diazyme cystatin C immunoassay measurements are significantly affected by the presence of turbidity in serum samples. Turbidity interference results in a significant over-estimation or under-estimation of serum cystatin C depending on the type of assay. There is an even higher over-estimation or under-estimation of GFR. For Roche, Diazyme and Dako cystatin C assays respectively, the over-estimation or under-estimation of cystatin C can be as high as 25%, 50% and 10%. When these figures are used to calculate GFR then the over-estimation or under-estimation of GFR can be as high as, respectively, 60%, 70% and 18%.

Roche, Diazyme and Dako cystatin C immunoassays show significant deviations from expected values due to interference from turbidity.

Gentian cystatin C immunoassay is insignificantly affected by turbidity in serum samples. The effect of turbidity does exist but is within an acceptable range for Gentian reagents.

Click here to download the Gentian vs. Roche, Diazyme and Dako turbidity poster presentation.

Gentian opens Chinese web pages

Gentian welcomes Chinese users to their own Chinese language web site. Click the buttons at top right on the Gentian home page.

Norwegian Gentian AS Beijing Rep. Office opens in China

Gentian has formed a new company - Norwegian Gentian AS Beijing Rep. Office - and opened an office in Beijing. Our first employee - Anita An - is engaged as our Chinese liaison officer.